StockWaves
  • Home
  • Global Markets
    Global MarketsShow More
    Celcuity Inventory Soars on Breakthrough Breast Most cancers Trial Outcomes
    Celcuity Inventory Soars on Breakthrough Breast Most cancers Trial Outcomes
    10 Min Read
    Down 47% and 29%! Listed here are the two worst-performing FTSE 100 dividend shares of 2025
    Down 47% and 29%! Listed here are the two worst-performing FTSE 100 dividend shares of 2025
    4 Min Read
    U.S. shares pare positive factors as traders await key earnings and financial information after US-EU commerce deal (SPX:null)
    U.S. shares pare positive factors as traders await key earnings and financial information after US-EU commerce deal (SPX:null)
    1 Min Read
    World baseline tariff will probably be 15% to twenty%
    World baseline tariff will probably be 15% to twenty%
    2 Min Read
    Itt inventory hits all-time excessive at 162.0 USD
    Itt inventory hits all-time excessive at 162.0 USD
    0 Min Read
  • Investment Strategies
    Investment StrategiesShow More
    DSP Mutual Fund declares revenue distribution
    DSP Mutual Fund declares revenue distribution
    0 Min Read
    Aditya Infotech IPO evaluation
    Aditya Infotech IPO evaluation
    0 Min Read
    Baroda BNP Paribas Mutual Fund declares earnings distribution below two funds
    Baroda BNP Paribas Mutual Fund declares earnings distribution below two funds
    0 Min Read
    IEX share worth sinks 4% as market coupling fears linger
    IEX share worth sinks 4% as market coupling fears linger
    0 Min Read
    Fund supervisor modifications within the ICICI Prudential India Alternatives Fund
    Fund supervisor modifications within the ICICI Prudential India Alternatives Fund
    0 Min Read
  • Market Analysis
    Market AnalysisShow More
    Waaree Energies Q1 Outcomes: Internet revenue soars 89% YoY to ₹745 crore, achieves document module output
    Waaree Energies Q1 Outcomes: Internet revenue soars 89% YoY to ₹745 crore, achieves document module output
    3 Min Read
    Will flexi, small-cap funds act like multi-asset funds quickly?
    Will flexi, small-cap funds act like multi-asset funds quickly?
    0 Min Read
    Wall Road Dwell: Dow Jones, S&P 500, Nasdaq rise after US-EU commerce deal
    Wall Road Dwell: Dow Jones, S&P 500, Nasdaq rise after US-EU commerce deal
    0 Min Read
    Even temples now imagine in mutual funds. Do you?
    Even temples now imagine in mutual funds. Do you?
    0 Min Read
    Intel to chop 15% of its workforce amid a .9 billion Q2 loss. How you can commerce the chipmaker’s inventory now?
    Intel to chop 15% of its workforce amid a $2.9 billion Q2 loss. How you can commerce the chipmaker’s inventory now?
    5 Min Read
  • Trading
    TradingShow More
    MARA Holdings Inventory Is Rising Monday: What’s Going On? – MARA Holdings (NASDAQ:MARA)
    MARA Holdings Inventory Is Rising Monday: What’s Going On? – MARA Holdings (NASDAQ:MARA)
    3 Min Read
    Uncommon Earths Are The Power Transition’s Hidden Bottleneck, Research Reveals – Apple (NASDAQ:AAPL), MP Supplies (NYSE:MP)
    Uncommon Earths Are The Power Transition’s Hidden Bottleneck, Research Reveals – Apple (NASDAQ:AAPL), MP Supplies (NYSE:MP)
    4 Min Read
    AI Speeds Up Work—However Simply Leads To Espresso Breaks, Says Accenture Exec Who Urges Reinventing Roles, Not Simply Instruments – Accenture (NYSE:ACN), Amazon.com (NASDAQ:AMZN)
    AI Speeds Up Work—However Simply Leads To Espresso Breaks, Says Accenture Exec Who Urges Reinventing Roles, Not Simply Instruments – Accenture (NYSE:ACN), Amazon.com (NASDAQ:AMZN)
    3 Min Read
    Ray Dalio Says 15% In Bitcoin Or Gold Could Be Important As Fiat Currencies Face Devaluation Dangers – VanEck Gold Miners ETF (ARCA:GDX)
    Ray Dalio Says 15% In Bitcoin Or Gold Could Be Important As Fiat Currencies Face Devaluation Dangers – VanEck Gold Miners ETF (ARCA:GDX)
    3 Min Read
    Howard Lutnick Says Chip Import Probe Outcomes Due In 2 Weeks As Trump Threatens New Tariffs To Drive US Manufacturing Increase – NVIDIA (NASDAQ:NVDA), Apple (NASDAQ:AAPL)
    Howard Lutnick Says Chip Import Probe Outcomes Due In 2 Weeks As Trump Threatens New Tariffs To Drive US Manufacturing Increase – NVIDIA (NASDAQ:NVDA), Apple (NASDAQ:AAPL)
    3 Min Read
Reading: Prime 10 Pharmaceutical Corporations in India in 2025
Share
Font ResizerAa
StockWavesStockWaves
  • Home
  • Global Markets
  • Investment Strategies
  • Market Analysis
  • Trading
Search
  • Home
  • Global Markets
  • Investment Strategies
  • Market Analysis
  • Trading
Follow US
2024 © StockWaves.in. All Rights Reserved.
StockWaves > Financial News > Prime 10 Pharmaceutical Corporations in India in 2025
Financial News

Prime 10 Pharmaceutical Corporations in India in 2025

StockWaves By StockWaves Last updated: April 2, 2025 7 Min Read
Prime 10 Pharmaceutical Corporations in India in 2025
SHARE




April 1, 2025April 1, 2025



India’s pharmaceutical business is on the rise, with its prime corporations changing into key gamers on the worldwide stage. Behind their success lies a mix of innovation, cutting-edge analysis, and a drive to enhance healthcare worldwide—making them a power to be reckoned with.

On this article, we take a more in-depth take a look at the highest 10 pharmaceutical corporations in India in 2025—every one shaping the way forward for world well being with groundbreaking options and noteworthy development.

Prime 10 Indian Pharma Corporations

Firm TitleMarket Cap (in Rs. Crore)52-Week Excessive (in Rs.)
Pfizer Ltd18,4366,451.15
Solar Pharmaceutical Industries Ltd405,4871,960.35
Cipla Ltd116,4091,702.05
Divi’s Laboratories Ltd147,6536,285.45
Dr Reddy’s Laboratories Ltd95,9161,421.49
Zydus Lifesciences Ltd88,0651,324.30
Mankind Pharma Ltd101,0383,054.80
Ajanta Pharma Ltd32,4783,485.00
Torrent Prescription drugs Ltd107,6593,590.70
Lupin Ltd89,2762,402.90

Now, let’s delve deeper into every of those main pharmaceutical giants:

Pfizer India

  • Managing Director: Sridhar Venkatesh
  • Complete Workforce: Roughly 2,600
  • Overview: Pfizer India, the Indian arm of Pfizer Inc, specialises in producing and advertising medicines throughout varied therapeutic classes, together with vaccines and oncology remedies. The corporate has been instrumental in introducing progressive therapies that cater to numerous well being wants.

Solar Pharmaceutical Industries Ltd

  • Managing Director: Dilip Shanghvi
  • Complete Workforce: Over 36,000
  • Overview: Solar Pharma is India’s largest pharmaceutical firm, rating because the sixth-largest generic producer globally. It operates in over 100 nations and specialises in a variety of therapeutic areas.

Cipla Ltd

  • Complete Workforce: Over 25,000
  • Overview: Cipla is a number one Indian multinational that develops medicines throughout a number of therapeutic areas, together with respiratory, cardiovascular, and most cancers therapy. Its world attain spans over 150 nations.

Divi’s Laboratories Ltd

  • Managing Director: Murali Krishna Prasad Divi
  • CEO: Satchandra Kiran Divi
  • Complete Workforce: Roughly 13,884
  • Overview: Divi’s Laboratories is a number one producer of energetic pharmaceutical substances (APIs) and intermediates, supplying to main pharmaceutical corporations throughout the globe.

Dr. Reddy’s Laboratories Ltd

  • Chairman: Kallam Satish Reddy
  • Co-Chairman & MD: G. V. Prasad
  • Complete Workforce: Roughly 24,832 (as of March 2023)
  • Overview: Dr. Reddy’s Laboratories is a multinational pharmaceutical firm that manufactures a variety of pharmaceutical merchandise, together with generics, biosimilars, and proprietary medicines, serving markets worldwide.

Zydus Lifesciences Ltd

  • Chairman: Pankaj R. Patel
  • Managing Director: Sharvil P. Patel
  • Complete Workforce: Over 25,000
  • Overview: Previously often called Cadila Healthcare, Zydus Lifesciences is a worldwide pharmaceutical chief identified for its generics, biosimilars, and branded formulations throughout a number of therapeutic areas.

Mankind Pharma Ltd

Yr of Basis: 1991

Chairman: Ramesh C. Juneja

Managing Director & Vice Chairman: Rajeev Juneja

CEO: Sheetal Arora

Complete Workforce: Over 22,000

Overview: Mankind Pharma is certainly one of India’s main pharmaceutical corporations, offering a broad vary of medicines in therapeutic areas like cardiovascular, anti-diabetic, and gastroenterology.

Ajanta Pharma Ltd

  • Managing Director: Yogesh M. Agrawal
  • Complete Workforce: Roughly 7,000
  • Overview: Ajanta Pharma is a specialty pharmaceutical firm specializing in the event, manufacturing, and advertising of high-quality formulations in each home and worldwide markets.

Torrent Prescription drugs Ltd

  • Complete Workforce: Over 13,000
  • Overview: Torrent Prescription drugs is a outstanding participant in India’s pharmaceutical sector, identified for its presence in therapeutic areas similar to cardiovascular, central nervous system, and gastrointestinal remedies.

Lupin Ltd

  • Complete Workforce: Over 22,000
  • Overview: Lupin is a transnational pharmaceutical firm identified for creating and delivering a variety of branded and generic formulations, biotechnology merchandise, and energetic pharmaceutical substances (APIs) worldwide.

Backside Line

These pharmaceutical giants should not solely shaping India’s healthcare panorama but in addition contributing considerably to world well being developments. Their continued innovation, analysis, and manufacturing capabilities promise to pave the way in which for future breakthroughs, guaranteeing their place as key gamers on the world stage.

Incessantly Requested Questions (FAQs)

1. Which is the biggest pharmaceutical firm in India in 2025?

Solar Pharmaceutical Industries Ltd holds the title of the biggest pharmaceutical firm in India, with a market cap of Rs. 405,487 crore.

2. What are the first therapeutic areas of Cipla Ltd?

Cipla Ltd focuses on therapeutic areas similar to respiratory, cardiovascular, and oncology.

3. Which pharmaceutical firm has the very best workforce in India?

Solar Pharmaceutical Industries Ltd employs over 36,000 individuals, the very best amongst Indian pharma corporations.

4. What’s the world presence of Zydus Lifesciences?

Zydus Lifesciences operates globally, specialising in generics, biosimilars, and branded formulations.

Curious About Pharma Shares? Ask the Analyst.

Unlock worthwhile alternatives on daily basis! Unicorn Indicators offers actionable intraday buying and selling alerts for shares and futures. Don’t miss out – obtain Unicorn Indicators and begin successful now!



Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.

By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Twitter Copy Link Print
Previous Article Oil costs regular as market awaits contemporary US tariffs Oil costs regular as market awaits contemporary US tariffs
Next Article Climate at this time: IMD points orange alert, predicts rainfall in Maharashtra, Andhra Pradesh and 4 different states Climate at this time: IMD points orange alert, predicts rainfall in Maharashtra, Andhra Pradesh and 4 different states
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

FacebookLike
TwitterFollow
PinterestPin
InstagramFollow

Subscribe Now

Subscribe to our newsletter to get our newest articles instantly!

Most Popular
q1 earnings: BEL to Swiggy: Q1 earnings in focus this week – The Financial Occasions Video
q1 earnings: BEL to Swiggy: Q1 earnings in focus this week – The Financial Occasions Video
July 28, 2025
Celcuity Inventory Soars on Breakthrough Breast Most cancers Trial Outcomes
Celcuity Inventory Soars on Breakthrough Breast Most cancers Trial Outcomes
July 28, 2025
DSP Mutual Fund declares revenue distribution
DSP Mutual Fund declares revenue distribution
July 28, 2025
Waaree Energies Q1 Outcomes: Internet revenue soars 89% YoY to ₹745 crore, achieves document module output
Waaree Energies Q1 Outcomes: Internet revenue soars 89% YoY to ₹745 crore, achieves document module output
July 28, 2025
NFT Gross sales Hit +0M In The Previous 7 Days
NFT Gross sales Hit +$200M In The Previous 7 Days
July 28, 2025

You Might Also Like

Inexperienced vitality inventory hits 5% higher circuit after receiving ₹31 Cr order from Uttar Pradesh Govt.
Financial News

Inexperienced vitality inventory hits 5% higher circuit after receiving ₹31 Cr order from Uttar Pradesh Govt.

6 Min Read
Checklist of Synthetic Intelligence Shares | AI Sector in India
Financial News

Checklist of Synthetic Intelligence Shares | AI Sector in India

24 Min Read
Shares in Focus: Ashoka Buildcon, JSW Power, and Others
Financial News

Shares in Focus: Ashoka Buildcon, JSW Power, and Others

5 Min Read
IT shares see worst month-to-month drop in 5 years. Wasn’t there an air of optimism simply months in the past?
Financial News

IT shares see worst month-to-month drop in 5 years. Wasn’t there an air of optimism simply months in the past?

5 Min Read

Always Stay Up to Date

Subscribe to our newsletter to get our newest articles instantly!

StockWaves

We provide tips, tricks, and advice for improving websites and doing better search.

Latest News

  • About Us
  • Contact Us
  • Privacy Policy
  • Terms Of Service

Resouce

  • Blockchain
  • Business
  • Economics
  • Financial News
  • Global Markets
  • Investment Strategies
  • Market Analysis
  • Trading

Trending

q1 earnings: BEL to Swiggy: Q1 earnings in focus this week – The Financial Occasions Video
Celcuity Inventory Soars on Breakthrough Breast Most cancers Trial Outcomes
DSP Mutual Fund declares revenue distribution

2024 © StockWaves.in. All Rights Reserved.

Welcome Back!

Sign in to your account

Not a member? Sign Up